4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
CellSource Co., Ltd. (4880) operates in the Biotechnology industry and is headquartered in Shibuya, Japan with about 148 employees. Its market capitalization is roughly JPY 7 billion. In the fiscal year ended 2025-10-31, 4880 reported JPY 3.7B in revenue and JPY 11M in net income.
CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan.
Interactive charts & full statements →
| Income statement | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Total Revenue | JPY 3.7B | JPY 4.4B | JPY 4.5B | JPY 4.3B | — |
| Gross Profit | JPY 2.1B | JPY 2.4B | JPY 3.2B | JPY 3.1B | — |
| Operating Income (EBIT) | JPY 167M | JPY 129M | JPY 1.2B | JPY 1.6B | — |
| Net Income | JPY 11M | JPY 238M | JPY 923M | JPY 1.0B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 99M) | (JPY 394M) | — | — | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Total Assets | JPY 7.0B | JPY 7.1B | JPY 6.9B | JPY 4.6B | — |
| Total Liabilities | JPY 1.0B | JPY 1.0B | JPY 678M | JPY 814M | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4880 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms